English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy. PPCM is not well understood and relatively little is known about its epidemiology and pathogenesis. However, it appears to have a more favourable prognosis compared with other causes of heart failure (HF) with a significant proportion of patients experiencing recovery of left ventricular (LV) function. As such, the optimal therapeutic strategy in severely affected patients is not clear currently. We report a case of severe PPCM in a 19‑year‑old woman who was managed successfully with implantation of a left ventricular assist device and aggressive pharmacotherapy with the aim of promoting myocardial recovery. She experienced marked improvement in both symptoms and left ventricular function which was sustained following LVAD explantation. JRCD 2013; 1 (5): 17–19

journal of rare cardiovascular diseases

Successful reversal of advanced heart failure due to peripartum cardiomyopathy with aggressive pharmacotherapy and a continuous-flow left ventricular assist device (RCD code: III-1B.8c)